← Open Payments lookup

AMY MURDOCK: Open Payments

NPI 1811535149 · NEDERLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 35 payments from 9 companies in 2025. Trend: 2023 $517 · 2024 $555 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$167
Novo Nordisk Inc18$162
ABBVIE INC.4$85
AstraZeneca Pharmaceuticals LP2$37
Galderma Laboratories, L.P.1$24
Lilly USA, LLC1$19
BIOTRONIK NRO, Inc.1$17
Abbott Laboratories1$17
Supernus Pharmaceuticals, Inc.1$16

Products named: CAPLYTA, Wegovy, Rybelsus, UBRELVY, VRAYLAR, ZEPBOUND, BREZTRI, FARXIGA.

Industry payments across TX — which companies pay providers there.